Amol Akhade/hiranandanihospital.org
Feb 8, 2025, 12:17
Amol Akhade: What is interesting in ASCO GU25
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:
“What is interesting in ASCO GU25.
1 – Surgery vs RT for High Risk Prostate cancer. -IPD Data from 2 RCT
2 – OS for checkmate274
3 – PCR analysis for Nigeria trial
4 – Final OS for Talapro-2 trial
5 – management of biochemical recurrence after RT for localized ca prostate.
6 – management of oligometastatic prostate cancer.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 17:45
May 29, 2025, 17:39
May 29, 2025, 17:28
May 29, 2025, 16:50